RWM
IRWD icon

Rialto Wealth Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Rialto Wealth Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.63K Buy
+2,174
New +$8.91K ﹤0.01% 506

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Rialto Wealth Management's IRWD Position: Q1 2026 in Review

Rialto Wealth Management opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 2,174 shares worth $7.63K. The stake represents ﹤0.01% of the portfolio and ranks #506 among its holdings.

226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Rialto Wealth Management held 2,174 shares of Ironwood Pharmaceuticals worth $7.63K as of Q1 2026.
  • Ironwood Pharmaceuticals was a new Rialto Wealth Management position in Q1 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Rialto Wealth Management's portfolio in Q1 2026, its #506 holding.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Rialto Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.